摘要
背景:电化学疗法(ECT)是电穿孔(EP)和化学疗法的组合,并且已经被报道为放射疗法的潜在放射增敏剂。 目的:本研究的主要目的是系统回顾文献以评估ECT在肿瘤对电离辐射敏感性中的有效性。另外还讨论了放射增敏作用的临床考虑和作用机制。 结果:本研究纳入了9项研究。博来霉素和顺铂与EP联合方案显示放射增敏作用。 EP增加博来霉素和顺铂的细胞毒性分别为1000倍和100倍。这些药物的作用机制是诱导DNA分子中的单链和双链断裂。而且,EP的两个主要机制是增加肿瘤细胞中的药物摄取并产生活性氧。放疗前单次ECT可显着增强肿瘤反应。 结论:ECT对于不同细胞系和肿瘤具有不同程度的放射敏感性。我们的研究结果表明,ECT可以进一步转化为临床,并可以通过单光照射和分割方式进行匹配。
关键词: 电穿孔,电化学疗法,癌症治疗,放射增敏效应,放射疗法,肿瘤。
图形摘要
Current Drug Targets
Title:Radiosensitizing Effect of Electrochemotherapy: A Systematic Review of Protocols and Efficiency
Volume: 18 Issue: 16
关键词: 电穿孔,电化学疗法,癌症治疗,放射增敏效应,放射疗法,肿瘤。
摘要: Background: Electrochemotherapy (ECT) is a combination of electroporation (EP) and chemotherapy and has been reported as a potential radiosensitizing agent for radiation therapy.
Objective: The main objective of this study was to systematically review of the literature to evaluate the effectiveness of ECT in sensitization of tumors to ionization radiation. In addition, the clinical considerations and mechanisms of action of radiosensitizing effect are discussed.
Results: Nine studies were included in this review. Bleomycin and cisplatin showed radiosensitizing effects in combined protocols with EP. EP enhances the cytotoxicity of bleomycin and cisplatin by factor of 1000 and 100, respectively. The mechanism of action of these drugs is induction of single and double strand breaks in DNA molecule. Moreover, the two main mechanisms of EP are increasing drug uptake in the tumor cells and generating reactive oxygen species. A single session ECT before radiotherapy can significantly enhance the tumor response.
Conclusion: ECT is effective for different cell lines and tumors with different levels of radiosensitivity. Our findings show that ECT can be further translated into the clinic and can be matched by singledose irradiation as well as in the fractionated regime.
Export Options
About this article
Cite this article as:
Radiosensitizing Effect of Electrochemotherapy: A Systematic Review of Protocols and Efficiency, Current Drug Targets 2017; 18 (16) . https://dx.doi.org/10.2174/1389450118666170622091014
DOI https://dx.doi.org/10.2174/1389450118666170622091014 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genetics of Cancer Susceptibility
Current Genomics Possible Involvement of Angiogenesis in Chronic Liver Diseases: Interaction Among Renin-Angiotensin-Aldosterone System, Insulin Resistance and Oxidative Stress
Current Medicinal Chemistry Immunogenicity and Tumorigenicity of Pluripotent Stem Cells and their Derivatives: Genetic and Epigenetic Perspectives
Current Stem Cell Research & Therapy Conditionally Replicating Adenoviruses for Cancer Treatment
Current Cancer Drug Targets IL-24: Physiological and Supraphysiological Effects on Normal and Malignant Cells
Current Medicinal Chemistry Discovery of MINC1, a GTPase-Activating Protein Small Molecule Inhibitor, Targeting MgcRacGAP
Combinatorial Chemistry & High Throughput Screening Recent Development in Fluorescent Probes for Copper Ion Detection
Current Topics in Medicinal Chemistry Fibroblast Growth Factors in Development and Cancer: Insights from the Mammary and Prostate Glands
Current Drug Targets Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases
Current Medicinal Chemistry Transdermal Delivery of 5-Fluorouracil for Induced Ehrlich Ascites Carcinoma Tumor in Balb/c Mice and Pharmacokinetic Study
Recent Patents on Anti-Cancer Drug Discovery GLUT4 Goes Abnormal: Disregulation of the Insulin-Responsive Glucose Transporter in Abnormal Metabolic States
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Hormetic Potential of Sulforaphane (SFN) in Switching Cells’ Fate Towards Survival or Death
Mini-Reviews in Medicinal Chemistry Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression
Current Molecular Medicine Topical Calcineurin Inhibitors, Pimecrolimus and Tacrolimus
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Beneficial Action of Citrus Flavonoids on Multiple Cancer-Related Biological Pathways
Current Cancer Drug Targets New Approaches to Target the Androgen Receptor and STAT3 for Prostate Cancer Treatments
Mini-Reviews in Medicinal Chemistry Role of Resistin in Insulin Sensitivity in Rodents and Humans
Current Protein & Peptide Science Nucleocytoplasmic Glycosylation, O-linked β-N-Acetylglucosamine
Current Organic Chemistry Relevance of the Neuropeptide Y System in the Biology of Cancer Progression
Current Topics in Medicinal Chemistry The IGF Axis in Prostate Cancer
Current Pharmaceutical Design